David J. Lockhart

2008

In 2008, David J. Lockhart earned a total compensation of $944.6K as Chief Scientific Officer at Amicus Therapeutics, a 6% decrease compared to previous year.

Compensation breakdown

Bonus$93,713
Option Awards$470,783
Salary$335,534
Other$44,590
Total$944,620

Lockhart received $470.8K in option awards, accounting for 50% of the total pay in 2008.

Lockhart also received $93.7K in bonus, $335.5K in salary and $44.6K in other compensation.

Rankings

In 2008, David J. Lockhart's compensation ranked 4,563rd out of 9,135 executives tracked by ExecPay. In other words, Lockhart earned more than 50.0% of executives.

ClassificationRankingPercentile
All
4,563
out of 9,135
50th
Division
Manufacturing
1,633
out of 3,436
53rd
Major group
Chemicals And Allied Products
319
out of 815
61st
Industry group
Drugs
192
out of 597
68th
Industry
Pharmaceutical Preparations
140
out of 408
66th
Source: SEC filing on April 25, 2011.

Lockhart's colleagues

We found four more compensation records of executives who worked with David J. Lockhart at Amicus Therapeutics in 2008.

2008

John Crowley

Amicus Therapeutics

Chairman

2008

James Dentzer

Amicus Therapeutics

Chief Financial Officer

2008

Matthew Patterson

Amicus Therapeutics

Chief Executive Officer

2008

Gregory Licholai

Amicus Therapeutics

Vice President, Medical Affairs

You may also like